Home

Posodobitev Joka Nabiranje p glycoprotein inhibitors list Paša bolnišnica Vlagatelj

Low-Dose Colchicine for Coronary Artery Disease | The Medical Letter Inc.
Low-Dose Colchicine for Coronary Artery Disease | The Medical Letter Inc.

List of some P-gp inhibitors belonging to three known generations. |  Download Table
List of some P-gp inhibitors belonging to three known generations. | Download Table

Selected substrates and modulators of P-glycoprotein | Download Table
Selected substrates and modulators of P-glycoprotein | Download Table

Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in  Pharmacoresistant Schizophrenia Therapy
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy

IJMS | Free Full-Text | Novel Heat Shock Protein 90 Inhibitors Suppress P- Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells
IJMS | Free Full-Text | Novel Heat Shock Protein 90 Inhibitors Suppress P- Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells

The role of P-glycoprotein and organic anion-transporting polypeptides in  drug interactions - Document - Gale OneFile: Health and Medicine
The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions - Document - Gale OneFile: Health and Medicine

Moderate to Strong P-gp Inhibitors and inducers | Download Table
Moderate to Strong P-gp Inhibitors and inducers | Download Table

Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein  Inhibition Activities for Potential Cancer Therapeutics
Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics

Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein  Inhibition Activities for Potential Cancer Therapeutics
Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics

Apixaban (Eliquis®) – Drug-Drug-Interaction Considerations in COVID-19  Patients with Coagulation Abnormalities - Anesthesia Patient Safety  Foundation
Apixaban (Eliquis®) – Drug-Drug-Interaction Considerations in COVID-19 Patients with Coagulation Abnormalities - Anesthesia Patient Safety Foundation

Glycoprotein P Inhibitor - an overview | ScienceDirect Topics
Glycoprotein P Inhibitor - an overview | ScienceDirect Topics

Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as  Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability  - Pharma Excipients
Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability - Pharma Excipients

Table 1.4 from P-glycoprotein inhibition as a strategy to increase drug  delivery across the blood-brain barrier: focus on antidepressants |  Semantic Scholar
Table 1.4 from P-glycoprotein inhibition as a strategy to increase drug delivery across the blood-brain barrier: focus on antidepressants | Semantic Scholar

Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment |  Journal of Medicinal Chemistry
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment | Journal of Medicinal Chemistry

P-glycoprotein
P-glycoprotein

Therapeutic agents that are P-glycoprotein substrates or inhibitors |  Download Table
Therapeutic agents that are P-glycoprotein substrates or inhibitors | Download Table

Common P-glycoprotein inhibitors and inducers | Download Table
Common P-glycoprotein inhibitors and inducers | Download Table

SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook  Overview of P-glycoprotein inhibitors: a rational outlook
SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook

Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced  mortality of multidrug resistant tumor cells | Scientific Reports
Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells | Scientific Reports

SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook  Overview of P-glycoprotein inhibitors: a rational outlook
SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook

Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in  Pharmacoresistant Schizophrenia Therapy
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy

Table 1 from Emerging significance of flavonoids as P-glycoprotein  inhibitors in cancer chemotherapy. | Semantic Scholar
Table 1 from Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | Semantic Scholar

Cardio-Oncology Drug Interactions: A Scientific Statement From the American  Heart Association | Circulation
Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association | Circulation

P-glycoprotein can interact with cardiovascular drugs
P-glycoprotein can interact with cardiovascular drugs

SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook  Overview of P-glycoprotein inhibitors: a rational outlook
SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook